Sensus Healthcare to Participate in the 37th Annual ROTH Conference
Sensus Healthcare (Nasdaq: SRTS), a medical device company focused on non-invasive and minimally-invasive treatments for skin conditions, has announced its participation in the 37th Annual ROTH Conference. The event is scheduled for March 17-18 in Dana Point, California.
The company, which specializes in treatments for both oncological and non-oncological skin conditions, will be conducting one-on-one meetings with registered investors during the conference. Interested registered attendees can schedule meetings with Sensus Healthcare management through their ROTH representative or by contacting Tirth Patel at Alliance Advisors.
Sensus Healthcare (Nasdaq: SRTS), un'azienda di dispositivi medici focalizzata su trattamenti non invasivi e minimamente invasivi per le condizioni della pelle, ha annunciato la sua partecipazione alla 37ª Conferenza Annuale ROTH. L'evento si svolgerà dal 17 al 18 marzo a Dana Point, California.
L'azienda, specializzata in trattamenti per condizioni della pelle oncologiche e non oncologiche, condurrà incontri individuali con investitori registrati durante la conferenza. Gli interessati possono programmare incontri con la direzione di Sensus Healthcare tramite il loro rappresentante ROTH o contattando Tirth Patel di Alliance Advisors.
Sensus Healthcare (Nasdaq: SRTS), una empresa de dispositivos médicos centrada en tratamientos no invasivos y mínimamente invasivos para afecciones cutáneas, ha anunciado su participación en la 37ª Conferencia Anual ROTH. El evento está programado para el 17 y 18 de marzo en Dana Point, California.
La empresa, que se especializa en tratamientos para afecciones cutáneas tanto oncológicas como no oncológicas, llevará a cabo reuniones individuales con inversores registrados durante la conferencia. Los asistentes registrados interesados pueden programar reuniones con la dirección de Sensus Healthcare a través de su representante de ROTH o contactando a Tirth Patel de Alliance Advisors.
Sensus Healthcare (Nasdaq: SRTS), 피부 질환을 위한 비침습적 및 최소 침습적 치료에 집중하는 의료 기기 회사가 제37회 연례 ROTH 컨퍼런스에 참여한다고 발표했습니다. 이 행사는 3월 17일부터 18일까지 캘리포니아주 다나 포인트에서 열립니다.
이 회사는 종양학적 및 비종양학적 피부 질환 치료를 전문으로 하며, 컨퍼런스 기간 동안 등록된 투자자들과 일대일 회의를 진행할 예정입니다. 관심 있는 등록 참석자는 ROTH 대표를 통해 Sensus Healthcare 경영진과 회의를 예약하거나 Alliance Advisors의 Tirth Patel에게 연락할 수 있습니다.
Sensus Healthcare (Nasdaq: SRTS), une entreprise de dispositifs médicaux axée sur des traitements non invasifs et peu invasifs pour les affections cutanées, a annoncé sa participation à la 37e Conférence Annuelle ROTH. L'événement est prévu pour les 17 et 18 mars à Dana Point, Californie.
L'entreprise, spécialisée dans les traitements pour les affections cutanées oncologiques et non oncologiques, organisera des réunions individuelles avec des investisseurs inscrits pendant la conférence. Les participants intéressés peuvent planifier des réunions avec la direction de Sensus Healthcare par l'intermédiaire de leur représentant ROTH ou en contactant Tirth Patel d'Alliance Advisors.
Sensus Healthcare (Nasdaq: SRTS), ein Medizintechnikunternehmen, das sich auf nicht-invasive und minimal-invasive Behandlungen von Hauterkrankungen spezialisiert hat, hat seine Teilnahme an der 37. jährlichen ROTH-Konferenz angekündigt. Die Veranstaltung findet am 17. und 18. März in Dana Point, Kalifornien, statt.
Das Unternehmen, das auf Behandlungen für sowohl onkologische als auch nicht-onkologische Hauterkrankungen spezialisiert ist, wird während der Konferenz Einzelgespräche mit registrierten Investoren führen. Interessierte registrierte Teilnehmer können Meetings mit dem Management von Sensus Healthcare über ihren ROTH-Vertreter oder durch Kontaktaufnahme mit Tirth Patel von Alliance Advisors vereinbaren.
- None.
- None.
Registered attendees who would like to schedule a meeting with Sensus Healthcare management should contact their ROTH representative or Tirth Patel at tpatel@allianceadvisors.com.
About Sensus Healthcare
Sensus Healthcare, Inc. is a global pioneer in the development and delivery of non-invasive treatments for skin cancer and keloids. Leveraging its cutting-edge superficial radiotherapy (SRT and IG-SRT) technology, the company provides healthcare providers with a highly effective, patient-centric treatment platform. With a dedication to driving innovation in radiation oncology, Sensus Healthcare offers solutions that are safe, precise, and adaptable to a variety of clinical settings. For more information, please visit www.sensushealthcare.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250313048513/en/
Alliance Advisors IR
Tirth T. Patel
tpatel@allianceadvisors.com
212-201-6614
Source: Sensus Healthcare, Inc.
FAQ
When and where is Sensus Healthcare (SRTS) participating in the ROTH Conference?
How can investors meet with SRTS management at the ROTH Conference?
What type of medical treatments does Sensus Healthcare (SRTS) specialize in?
What type of investor meetings is SRTS offering at the ROTH Conference?
